GHRP-6 has no single legal status. It depends on the product and how it is supplied.
No FDA-approved human GHRP-6 product was identified in the checked U.S. databases as of August 30, 2026. A research use only label does not make a product approved for people.
Pharmacy mixing (compounding): FDA lists it in Category 2 for possible safety risks (FDA page dated April 22, 2026).
Sports: the anti-doping rules we checked list it as prohibited (checked August 30, 2026).
Rules for buying, selling, and prescribing also depend on how a product is made and sold, and on state law.
This is not legal advice.
Whether you may buy, sell, or use a product also depends on pharmacy (compounding) rules, a prescription, and state law. Read how U.S. peptide law works.
The record found no FDA-approved product. A label that says research use only does not make a product approved for people.
What the record says: No FDA-approved human GHRP-6 product was identified in the checked U.S. databases as of August 30, 2026
Is it on FDA's compounding safety list?
Category 2: safety risk
Listed under the 503B policy.
FDA placed it here because it may present significant safety risks in compounding, pending further review. Each entry names the policy it falls under: 503A covers pharmacies, and 503B covers outsourcing facilities.
The 2026 WADA Prohibited List names GHRP-6 under growth hormone-releasing factors. It is prohibited in and out of competition. This page is not personal clearance. Athletes must check the current rules that apply to them.
Checked . Read the rule we checked. Check the current World Anti-Doping Agency list and your sport's rules before you compete.
Other names in this record: Growth hormone-releasing peptide 6, Growth hormone-releasing hexapeptide, SKF-110679.
Go further
Read the full GHRP-6 record
What it is, what studies in people show, and what is still unknown.